Market News & Trends
Third Critically Ill Patient Successfully Treated With PLX Cells Under Compassionate Use
Pluristem Therapeutics, Inc. recently announced the company's Placental eXpanded (PLX) cells were successfully administered to a third patient in Hadassah Medical Center; thus, a series…
West Announces Self-Injection Technology Agreement
West recently announced an agreement with Janssen Biotech, Inc. to collaborate on the development and manufacturing of an innovative self-injection product. The technology, developed by…
Thermo Fisher Announces New Method
Thermo Fisher Scientific recently announced a new method that can automatically extract glycoproteins from samples, and glycopeptides from tryptic digests, thus enabling faster isolation, better…
9/5/2012
Genmab Signs Potential Billion Dollar Agreement Genmab recently announced a global license and development agreement for daratumumab (HuMax-CD38), a human CD38 monoclonal antibody with Janssen…
Charles River Buys Company for $17 Million
Charles River Laboratories International, Inc. recently announced it has acquired Accugenix, Inc., the premier global provider of cGMP-compliant contract microbial identification testing, for approximately $17…
Genmab Signs Potential Billion Dollar Agreement
Genmab recently announced a global license and development agreement for daratumumab (HuMax-CD38), a human CD38 monoclonal antibody with Janssen Biotech, Inc., one of the Janssen…
Hovione Announces New Director
Hovione recently announced the appointment of Dr. Conrad Winters as Director, Drug Product Development. Dr. Winters was previously with Merck in US and Canada and…
SeraCare Expands HCV & HTLV Performance Panel Offerings
SeraCare Life Sciences recently announced it has expanded its performance panel product offerings. SeraCare's third Worldwide HCV RNA Performance Panel and eighth Anti-HTLV I/II Mixed…
Sunovion to Buy Company in Deal Worth $430 Million
Sunovion Pharmaceuticals Inc. recently announced it has signed a definitive agreement to acquire Elevation Pharmaceuticals, Inc. The acquisition includes Elevation Pharmaceuticals' EP-101 product, an inhalation…
8/29/2012
Synergy Pharmaceuticals Acquires BMS Drug Synergy Pharmaceuticals Inc. recently announced it has signed an Asset Purchase Agreement with Bristol-Myers Squibb Company and has acquired the…
Agile Therapeutics Announces Three New Patents for Patch Technology
Agile Therapeutics recently announced that the USPTO has issued three new patents with claims related to its contraceptive patch technology. The three new patents add…
Bend Research Announces New Facility for High-Potency Drug Candidates
Bend Research Inc. recently announced the addition of a new current Good Manufacturing Practice (cGMP) spray-drying facility. The new facility expands Bend Research's state-of-the-art capabilities…
DPT Laboratories Names New VP & GM of Center of Excellence
DPT Laboratories recently announced that Gene Ciolfi has been promoted to Vice President and General Manager, Site Operations, DPT Lakewood, NJ. Mr. Ciolfi, who joined…
ImmunoGen Announces Significant Phase III Study Results
ImmunoGen, Inc. recently announced that Roche has reported that updated results from its EMILIA Phase III trial show that patients treated with trastuzumab emtansine had a…
Pyramid Laboratories Expands cGMP Services
Pyramid Laboratories, Inc. a premier clinical and commercial parenteral manufacturer, recently announced it has expanded its portfolio of services with the addition of a new…
Synergy Pharmaceuticals Acquires BMS Drug
Synergy Pharmaceuticals Inc. recently announced it has signed an Asset Purchase Agreement with Bristol-Myers Squibb Company and has acquired the assets related to FV-100, an…
8/22/2012
United Drug Acquires Leading Clinical Trials Materials Business United Drug plc recently announced it has reached an agreement to acquire the UK and US clinical…
Avantor Names New President & CEO
Avantor Performance Materials recently announced the appointment of John M. Steitz as President and Chief Executive Officer. Mr. Steitz assumes these roles from Avantor Chairman…
New Findings Advance Industry Understanding of Standardizing In Vitro Tests for Lipid-Based Formulations
With the push to bring new drugs to market faster, the healthcare industry has made significant advances in utilizing lipid-based drug delivery systems to expedite…
Regulus Therapeutics Files for Multi-Million IPO
Regulus Therapeutics Inc., a biopharmaceutical company founded by Alnylam Pharmaceuticals and Isis Pharmaceuticals, recently announced it has filed a registration statement on Form S-1 with…
